drug

XPRO1595

1 story · latest Jun 29, 2026

Status: Investigational
Codes: DN-TNF, XENP1595
Trials: 1 registered trial in coverage

Relationships

Developed by Inmune Bio, Inc.

Timeline

InMune Bio posts results for Phase 2 XPro1595 trial in early Alzheimer's disease

Jun 29Trial updateInmune Bio, Inc.XPRO1595

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.